ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of CD4+ Conventional T Cells-Related lncRNA Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Breast Cancer

Ning, Shipeng; Wu, Jianbin; Pan, You; Qiao, Kun; Li, Lei*; Huang, Qinghua*哈尔滨医科大学
Frontiers in Immunology2022-5-4DOI: 10.3389/fimmu.2022.880769
7被引9阅读
引用收藏
分享

摘要

BackgroundBreast cancer (BC) is one of the most common malignancies in women, and long non-coding RNAs (lncRNAs) are key regulators of its development. T cells can recognize and kill cancer cells, and CD4(+) T conventional (Tconv) cells are the main orchestrators of cancer immune function. However, research on CD4(+) Tconv-related lncRNAs (CD4TLAs) prognostic signature in patients with BC is still lacking. MethodA TCGA database and a GEO database were used to collect the BC patients. Through LASSO Cox regression analysis CD4TLAs-related prognostic models were further constructed, and risk scores (RS) were generated and developed a nomogram based on CD4TLAs. The accuracy of this model was validated in randomized cohorts and different clinical subgroups. Gene set enrichment analysis (GSEA) was used to explore potential signature-based functions. The role of RS has been further explored in the tumor microenvironment (TME), immunotherapy, and chemotherapy. ResultA prognostic model based on 16 CD4TLAs was identified. High-RS was significantly associated with a poorer prognosis. RS was shown to be an independent prognostic indicator in BC patients. The low-RS group had a significant expression of immune infiltrating cells and significantly enriched immune-related functional pathways. In addition, the results of immunotherapy prediction indicated that patients with low-RS were more sensitive to immunotherapy. ConclusionsOur signature has potential predictive value for BC prognosis and immunotherapy response. The findings of this work have greatly increased our understanding of CD4TLA in BC.

学科与关键词

关键词
long non-coding RNACD4(+) conventional T cellsbreast cancerThe Cancer Genome Atlasprognostic signature
相关
加载中…
  • A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs
    Huang, Zhijian; Xiao, Chen; Zhang, Fushou; Zhou, Zhifeng; Yu, Liang; Ye, Changsheng*; Huang, Weiwei*; Li, Nani*Frontiers in Genetics, 2021, 11: 634195.被引 8
  • An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer
    Jiang, Hanwen; Sun, Jingxian; Liu, Fucong; Wu, Xincai; Wen, Zhaohui*Frontiers in Genetics, 2022, 13: 895200.被引 5
  • Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer
    Yang, Ming; Sun, Yutian; Ji, Hongfei*; Zhang, Qingyuan*Annals of Translational Medicine, 2022, 10(24): 1399.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-05-04
卷期
第 13 卷
页码
880769
DOI
10.3389/fimmu.2022.880769
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82002779, 81760478]; Guangxi Provincial Natural Science Foundation of China [2019GXNSFAA245083]; Youth Science Foundation of Guangxi Medical University [GXMUYSF202224]

作者

  • N

    Ning, Shipeng (第一作者)

    guangxi med univ

  • W

    Wu, Jianbin

    fujian med univ

查看全部 6 位作者收起作者
  • P

    Pan, You

    guangxi med univ

  • Q

    Qiao, Kun

    harbin med univ

  • L

    Li, Lei (通讯)

    new

  • H

    Huang, Qinghua (通讯)

    guangxi med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417